600285 羚锐制药
交易中 05-11 13:30:00
资讯
新帖
简况
每周股票复盘：羚锐制药（600285）2025年度拟每股派现1.10元
证券之星 · 05-02
每周股票复盘：羚锐制药（600285）2025年度拟每股派现1.10元
国金证券：给予羚锐制药买入评级
证券之星 · 04-29
国金证券：给予羚锐制药买入评级
羚锐制药（600285）披露获得盐酸氮䓬斯汀鼻喷雾剂药品注册证书公告，4月28日股价上涨5.22%
证券之星 · 04-28
羚锐制药（600285）披露获得盐酸氮䓬斯汀鼻喷雾剂药品注册证书公告，4月28日股价上涨5.22%
图解羚锐制药一季报：第一季度单季净利润同比增长13.61%
证券之星 · 04-28
图解羚锐制药一季报：第一季度单季净利润同比增长13.61%
羚锐制药（600285）披露关于使用闲置自有资金进行现金管理的公告，4月27日股价下跌0.65%
证券之星 · 04-27
羚锐制药（600285）披露关于使用闲置自有资金进行现金管理的公告，4月27日股价下跌0.65%
每周股票复盘：羚锐制药（600285）获铝碳酸镁咀嚼片注册证
证券之星 · 03-29
每周股票复盘：羚锐制药（600285）获铝碳酸镁咀嚼片注册证
羚锐制药（600285）披露大股东部分股份质押公告，3月24日股价上涨0.18%
证券之星 · 03-24
羚锐制药（600285）披露大股东部分股份质押公告，3月24日股价上涨0.18%
每周股票复盘：羚锐制药（600285）羚锐集团质押3735万股占总股本6.59%
证券之星 · 03-22
每周股票复盘：羚锐制药（600285）羚锐集团质押3735万股占总股本6.59%
羚锐制药（600285）披露大股东部分股份质押公告，3月19日股价下跌0.63%
证券之星 · 03-19
羚锐制药（600285）披露大股东部分股份质押公告，3月19日股价下跌0.63%
每周股票复盘：羚锐制药（600285）大股东质押股份用于经营周转
证券之星 · 01-18
每周股票复盘：羚锐制药（600285）大股东质押股份用于经营周转
羚锐制药（600285）股东河南羚锐集团有限公司质押170万股，占总股本0.3%
证券之星 · 01-14
羚锐制药（600285）股东河南羚锐集团有限公司质押170万股，占总股本0.3%
羚锐制药（600285）发布“提质增效重回报”行动方案，1月5日股价上涨4.88%
证券之星 · 01-05
羚锐制药（600285）发布“提质增效重回报”行动方案，1月5日股价上涨4.88%
每周股票复盘：羚锐制药（600285）推“提质增效重回报”行动方案
证券之星 · 01-02
每周股票复盘：羚锐制药（600285）推“提质增效重回报”行动方案
羚锐制药（600285）披露高级管理人员辞职公告，12月30日股价上涨1.07%
证券之星 · 2025-12-30
羚锐制药（600285）披露高级管理人员辞职公告，12月30日股价上涨1.07%
羚锐制药（600285）披露大股东部分股份解除质押，11月21日股价下跌1.38%
证券之星 · 2025-11-21
羚锐制药（600285）披露大股东部分股份解除质押，11月21日股价下跌1.38%
羚锐制药（600285）披露取消监事会并修订公司章程议案获通过，11月18日股价上涨0.27%
证券之星 · 2025-11-18
羚锐制药（600285）披露取消监事会并修订公司章程议案获通过，11月18日股价上涨0.27%
每周股票复盘：羚锐制药（600285）将召开2025年第三季度业绩说明会
证券之星 · 2025-11-16
每周股票复盘：羚锐制药（600285）将召开2025年第三季度业绩说明会
羚锐制药03月10日主力净流入65万元 散户资金抛售
市场透视 · 2025-03-10
羚锐制药03月10日主力净流入65万元 散户资金抛售
羚锐制药(600285.SH)：公司股东羚锐集团累计质押3213万股，年内公司股价跌幅近10%
有连云 · 2025-03-07
羚锐制药(600285.SH)：公司股东羚锐集团累计质押3213万股，年内公司股价跌幅近10%
公司概况
公司名称：
河南羚锐制药股份有限公司
所属行业：
医药制造业
上市日期：
2000-10-18
主营业务：
河南羚锐制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是贴剂、片剂、胶囊剂、软膏剂。2025年，公司入选“2024年度中国医药工业百强榜”。
发行价格：
8.30
{"stockData":{"symbol":"600285","market":"SH","secType":"STK","nameCN":"羚锐制药","latestPrice":21.9,"timestamp":1778477400000,"preClose":22.01,"halted":0,"volume":5346780,"delay":0,"changeRate":-0.005,"floatShares":566000000,"shares":567000000,"eps":1.3913,"marketStatus":"交易中","change":-0.11,"latestTime":"05-11 13:30:00","open":22.03,"high":22.08,"low":21.76,"amount":117000000,"amplitude":0.0145,"askPrice":21.9,"askSize":220,"bidPrice":21.88,"bidSize":129,"shortable":0,"etf":0,"ttmEps":1.3913,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778482800000},"marketStatusCode":2,"adr":0,"adjPreClose":22.01,"symbolType":"stock","openAndCloseTimeList":[[1778463000000,1778470200000],[1778475600000,1778482800000]],"highLimit":24.21,"lowLimit":19.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":567115486,"isCdr":false,"pbRate":3.42,"roa":"--","peRate":15.740674,"roe":"6.99%","epsLYR":1.34,"committee":-0.233103,"marketValue":12420000000,"turnoverRate":0.0094,"status":1,"floatMarketCap":12392000000},"requestUrl":"/m/hq/s/600285/wiki","defaultTab":"wiki","newsList":[{"id":"2632368644","title":"每周股票复盘：羚锐制药（600285）2025年度拟每股派现1.10元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632368644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632368644?lang=zh_cn&edition=full","pubTime":"2026-05-02 02:56","pubTimestamp":1777661770,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，羚锐制药报收于22.36元，较上周的21.59元上涨3.57%。本周，羚锐制药4月30日盘中最高价报22.93元。该方案尚需提交2025年年度股东会审议通过。公司发布2025年度社会责任报告，全年实现营业收入38.53亿元，净利润7.60亿元，同比增长10.07%和5.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0070","600285","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631553016","title":"国金证券：给予羚锐制药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631553016?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:47","pubTimestamp":1777423668,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对羚锐制药进行研究并发布了研究报告《业绩稳健增长，分红比例提升》，给予羚锐制药买入评级。 羚锐制药 业绩简评 2026年4月27日，公司发布2025年年报。2025年公司实现收入38.5亿元，归母净利润7.6亿元，扣非归母净利润7.1亿元。银谷制药2025年实现营收约3.12亿元，净利润约5060万元。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，增持评级1家；过去90天内机构目标均价为29.9。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900027259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630624583","title":"羚锐制药（600285）披露获得盐酸氮䓬斯汀鼻喷雾剂药品注册证书公告，4月28日股价上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630624583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630624583?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:03","pubTimestamp":1777385010,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，羚锐制药报收于22.57元，较前一交易日上涨5.22%，最新总市值为128亿元。该股当日开盘22.34元，最高22.85元，最低22.34元，成交额达5.91亿元，换手率为4.63%。近日，羚锐制药发布《关于获得药品注册证书的公告》。公告显示，公司子公司银谷制药有限责任公司收到国家药品监督管理局核准签发的盐酸氮斯汀鼻喷雾剂《药品注册证书》。银谷制药为该品种首家过评企业，累计投入约1,079.4万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800063923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600285","BK0239","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630312130","title":"图解羚锐制药一季报：第一季度单季净利润同比增长13.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630312130","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630312130?lang=zh_cn&edition=full","pubTime":"2026-04-28 03:58","pubTimestamp":1777319914,"startTime":"0","endTime":"0","summary":"证券之星消息，羚锐制药2026年一季报显示，一季度公司主营收入11.26亿元，同比上升10.32%；归母净利润2.46亿元，同比上升13.61%；扣非净利润2.28亿元，同比上升11.59%；负债率38.22%，投资收益1102.61万元，财务费用-610.3万元，毛利率78.19%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800011130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630768390","title":"羚锐制药（600285）披露关于使用闲置自有资金进行现金管理的公告，4月27日股价下跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630768390","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630768390?lang=zh_cn&edition=full","pubTime":"2026-04-27 22:26","pubTimestamp":1777299960,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘，羚锐制药报收于21.45元，较前一交易日下跌0.65%，最新总市值为121.65亿元。该股当日开盘21.59元，最高21.73元，最低21.24元，成交额达1.59亿元，换手率为1.31%。近日，羚锐制药发布《关于使用闲置自有资金进行现金管理的公告》。该事项尚需提交公司2025年年度股东会审议。公司已制定风险控制措施，确保资金安全，不影响日常经营和主营业务发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700046623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0070","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623333952","title":"每周股票复盘：羚锐制药（600285）获铝碳酸镁咀嚼片注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2623333952","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623333952?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:23","pubTimestamp":1774729389,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，羚锐制药报收于22.28元，较上周的22.49元下跌0.93%。本周，羚锐制药3月27日盘中最高价报22.55元。本周关注点公司公告汇总：羚锐制药获铝碳酸镁咀嚼片药品注册证书，视同通过仿制药一致性评价。羚锐集团及其一致行动人合计持股127,813,609股，累计质押37,900,000股，占公司总股本6.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0070","600285","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621093156","title":"羚锐制药（600285）披露大股东部分股份质押公告，3月24日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621093156","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621093156?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:17","pubTimestamp":1774361845,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘，羚锐制药报收于21.79元，较前一交易日上涨0.18%，最新总市值为123.57亿元。近日，羚锐制药发布《关于大股东部分股份质押的公告》。公告显示，公司大股东河南羚锐集团有限公司持有公司股份121,817,898股，占公司总股本的21.48%。本次质押550,000股后，累计质押股份37,900,000股，占其持股比例31.11%，占公司总股本6.68%。本次质押融资用途为经营流动资金周转，质权人为河南农村商业银行股份有限公司新县支行，质押起始日为2026年3月23日，至解除质押日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400039885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0077","BK0070","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621799954","title":"每周股票复盘：羚锐制药（600285）羚锐集团质押3735万股占总股本6.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621799954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621799954?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:57","pubTimestamp":1774119428,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，羚锐制药报收于22.49元，较上周的22.05元上涨2.0%。本周，羚锐制药3月20日盘中最高价报22.9元。本周关注点公司公告汇总：羚锐集团质押3735万股，占其所持股份30.66%，占公司总股本6.59%公司公告汇总羚锐制药关于大股东部分股份质押的公告河南羚锐集团有限公司持有羚锐制药股份121,817,898股，占公司总股本的21.48%。质押股份未用于重大资产重组业绩补偿等担保。羚锐集团及其一致行动人合计持股127,813,609股，累计质押37,350,000股，占公司总股本的6.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600285","BK0077","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620439812","title":"羚锐制药（600285）披露大股东部分股份质押公告，3月19日股价下跌0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620439812","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620439812?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:06","pubTimestamp":1773911165,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘，羚锐制药报收于22.04元，较前一交易日下跌0.63%，最新总市值为124.99亿元。该股当日开盘22.02元，最高22.24元，最低21.89元，成交额达1.3亿元，换手率为1.04%。近日，羚锐制药发布《关于大股东部分股份质押的公告》。公告显示，河南羚锐集团有限公司持有公司股份121,817,898股，占公司总股本的21.48%。本次质押7,300,000股后，累计质押股份37,350,000股，占其所持股份比例为30.66%，占公司总股本的6.59%。质押股份未用于重大资产重组业绩补偿等担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900027336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0070","BK0239","600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604234189","title":"每周股票复盘：羚锐制药（600285）大股东质押股份用于经营周转","url":"https://stock-news.laohu8.com/highlight/detail?id=2604234189","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604234189?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:01","pubTimestamp":1768676472,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，羚锐制药报收于20.94元，较上周的21.28元下跌1.6%。公司公告汇总羚锐制药关于大股东部分股份质押的公告河南羚锐集团有限公司持有公司21.48%股份，本次质押1,700,000股，占其持股比例1.40%，占公司总股本0.30%。质押股份未用于重大资产重组业绩补偿等担保。羚锐集团及其一致行动人合计持股22.54%，累计质押股份占公司总股本5.30%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","600285","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603692191","title":"羚锐制药（600285）股东河南羚锐集团有限公司质押170万股，占总股本0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603692191","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603692191?lang=zh_cn&edition=full","pubTime":"2026-01-14 18:30","pubTimestamp":1768386654,"startTime":"0","endTime":"0","summary":"证券之星消息，羚锐制药1月14日公开信息显示，股东河南羚锐集团有限公司向中国农业银行股份有限公司新县支行合计质押170.0万股，占总股本0.3%。质押详情见下表：截止本公告日，股东河南羚锐集团有限公司已累计质押股份3005.0万股，占其持股总数的24.67%。羚锐制药主营业务：药品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400033983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600285","BK0070","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601894000","title":"羚锐制药（600285）发布“提质增效重回报”行动方案，1月5日股价上涨4.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601894000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601894000?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:10","pubTimestamp":1767607823,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，羚锐制药报收于21.72元，较前一交易日上涨4.88%，最新总市值为123.18亿元。该股当日开盘21.3元，最高21.87元，最低21.18元，成交额达3.45亿元，换手率为2.83%。近日，羚锐制药披露了《“提质增效重回报”行动方案》。公告显示，公司为贯彻落实提高上市公司质量的相关要求，制定该行动方案。方案还提出建立长效回报机制，持续实施现金分红，并严格信息披露，提升透明度，加强投资者关系管理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500027791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0070","BK0077","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600627036","title":"每周股票复盘：羚锐制药（600285）推“提质增效重回报”行动方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2600627036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600627036?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:58","pubTimestamp":1767293890,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，羚锐制药报收于20.99元，较上周的21.34元下跌1.64%。本周，羚锐制药12月22日盘中最高价报21.38元。本周关注点公司公告汇总：羚锐制药发布“提质增效重回报”行动方案，强化贴膏剂市场地位。辞职报告自送达董事会之日起生效。羚锐制药关于“提质增效重回报”行动方案的公告河南羚锐制药股份有限公司为贯彻落实提高上市公司质量的相关要求，制定《“提质增效重回报”行动方案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600285","BK0070","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595535713","title":"羚锐制药（600285）披露高级管理人员辞职公告，12月30日股价上涨1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595535713","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595535713?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:41","pubTimestamp":1767105674,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，羚锐制药报收于20.74元，较前一交易日上涨1.07%，最新总市值为117.62亿元。公司近日发布公告称，河南羚锐制药股份有限公司董事会于近日收到副总经理武惠斌先生提交的辞职报告，其因公司内部工作调整，申请辞去公司副总经理职务。辞职报告自送达董事会之日起生效。截至公告日，武惠斌先生持有公司股份764,500股，占公司总股本的0.13%，将严格遵守相关减持规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0070","BK0077","600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585499941","title":"羚锐制药（600285）披露大股东部分股份解除质押，11月21日股价下跌1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585499941","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585499941?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:32","pubTimestamp":1763735522,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，羚锐制药报收于22.14元，较前一交易日下跌1.38%，最新总市值为125.56亿元。该股当日开盘22.4元，最高22.54元，最低22.12元，成交额达1.29亿元，换手率为1.02%。公司近日发布公告称，河南羚锐集团有限公司持有羚锐制药121,817,898股，占公司总股本的21.48%。羚锐集团本次解除质押的股份暂无后续质押计划。截至公告日，羚锐集团及其一致行动人合计持股127,813,609股，累计质押28,350,000股，占合计持股总数的22.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","600285","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584955561","title":"羚锐制药（600285）披露取消监事会并修订公司章程议案获通过，11月18日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584955561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584955561?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:26","pubTimestamp":1763475985,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，羚锐制药报收于22.26元，较前一交易日上涨0.27%，最新总市值为126.24亿元。公司近日发布公告称，河南羚锐制药股份有限公司于2025年11月18日召开2025年第一次临时股东大会，会议由董事长熊伟主持，采用现场与网络投票相结合方式召开，审议通过了关于取消监事会并修订《公司章程》的议案，以及多项公司治理制度修订议案，包括《股东会议事规则》《董事会议事规则》《独立董事工作制度》等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800039967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600285","BK0239","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583546686","title":"每周股票复盘：羚锐制药（600285）将召开2025年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2583546686","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583546686?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:42","pubTimestamp":1763239332,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，羚锐制药报收于22.68元，较上周的22.6元上涨0.35%。本周，羚锐制药11月12日盘中最高价报23.38元。羚锐制药当前最新总市值128.62亿元，在中药板块市值排名17/67，在两市A股市值排名1492/5165。本周关注点公司公告汇总：羚锐制药将于2025年11月19日召开第三季度业绩说明会，介绍经营成果并回应投资者提问。投资者可于2025年11月12日至11月18日16:00前通过上证路演中心或公司邮箱600285@lingrui.com提前提问。说明会结束后可通过该平台查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","BK0070","600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518213070","title":"羚锐制药03月10日主力净流入65万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518213070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518213070?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:22","pubTimestamp":1741591341,"startTime":"0","endTime":"0","summary":"03月10日, 羚锐制药股价涨1.92%，报收20.68元，成交金额1.57亿元，换手率1.34%，振幅2.17%，量比1.12。羚锐制药今日主力资金净流入65万元，上一交易日主力净流出1515万元。该股近5个交易日下跌0.29%，主力资金累计净流出1288万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1.24亿元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310164539a269b340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310164539a269b340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0239","BK0077","BK0070","600285"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517323436","title":"羚锐制药(600285.SH)：公司股东羚锐集团累计质押3213万股，年内公司股价跌幅近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517323436","media":"有连云","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517323436?lang=zh_cn&edition=full","pubTime":"2025-03-07 21:20","pubTimestamp":1741353600,"startTime":"0","endTime":"0","summary":"2025年3月7日，羚锐制药披露了关于大股东部分股份解除质押及再质押的公告。本次解除质押及再质押后，羚锐集团持有本公司股份累计质押数量为32130000股，占其持股数量比例为26.38%，占公司总股本的5.67%。 羚锐制药2024年三季报净利润为5.74亿元、同比较去年同期上涨23.10%。 股价表现上，截至2025年3月7日收盘，羚锐制药最新跌幅为0.49%，最新价20.29元，成交额1.18亿元，换手率1.03%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-07/doc-inenvwne9661555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","600285","BK0239","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778477403958,"stockEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":-0.0077},{"period":"3month","weight":-0.0103},{"period":"6month","weight":-0.0261},{"period":"1year","weight":-0.0019},{"period":"ytd","weight":0.0628}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南羚锐制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42365人(较上一季度减少1.10%)","perCapita":"13356股","listingDate":"2000-10-18","address":"河南省信阳市新县将军路666号","registeredCapital":"56711万元","survey":" 河南羚锐制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是贴剂、片剂、胶囊剂、软膏剂。2025年，公司入选“2024年度中国医药工业百强榜”。","listedPrice":8.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"羚锐制药(600285)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供羚锐制药(600285)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"羚锐制药,600285,羚锐制药股票,羚锐制药股票老虎,羚锐制药股票老虎国际,羚锐制药行情,羚锐制药股票行情,羚锐制药股价,羚锐制药股市,羚锐制药股票价格,羚锐制药股票交易,羚锐制药股票购买,羚锐制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"羚锐制药(600285)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供羚锐制药(600285)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}